Molecular Farming of BMPs and Fibronectin for Commercialization
Biobusiness Grant Recipient: Dave Roeser
Grant Period: 2020-2021
Award Value: $96,700
Site: MNPHARM SBC
Project Summary: We have seven specific milestones with the goal of making bone morphogenetic protein and fibronectin (used to promote bone repair) that is significantly less expensive than current materials, which will open the door to many new markets such as 3D printing that are cost prohibitive today. There is a large market for fibronectin that is not currently being met. We are developing optimization to scale the production to meet this demand. We strive to make the materials faster, safer, and at a reduced cost.